Clinical trials recruiting in Hsinchu, Taiwan

Phase breakdown

Conditions recruiting in Hsinchu, Taiwan

Recruiting trials in Hsinchu, Taiwan

• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
  NCT05211895 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
  NCT06226883 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female)
• A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
  NCT06103864 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
  NCT05774951 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
  NCT06077760 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
  NCT05456256 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
  NCT07438496 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
  NCT04928846 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
  NCT06065748 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
  NCT06807424 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
  NCT07363694 · Phase: Phase 2, Phase 3 · Ages: 35 Years to 80 Years · Sex: All (male and female)
• A Translational Study for Locoregional Recurrence of T4 Colon Cancer
  NCT06958926 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.
  NCT07182214 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07234032 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease
  NCT06630702 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 85 Years · Sex: All (male and female)
• Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma
  NCT07119580 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Compare the Patient Satisfaction and Effectiveness After Novel Application-based or Conventional Health Education of Bowel Preparation for Colonoscopy
  NCT06560671 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline
  NCT06069141 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease
  NCT06249945 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female)
• Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
  NCT06519474 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: All (male and female)
• Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes
  NCT06331338 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease
  NCT06249932 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female)
• Exercise Intervention to Improve Quality of Life in Patients With Colorectal Cancer
  NCT05224518 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: All (male and female)
• Formatting the Risk Prediction Models for Never-Smoking Lung Cancer
  NCT05572944 · Phase: Not specified · Ages: 20 Years to 80 Years · Sex: All (male and female)
• Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
  NCT02635022 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female)
• Multi-Modal Digital Interventions for Adolescent Weight Management
  NCT06920862 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female)
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Photobiomodulation Therapy in Patients Receiving Total Knee Arthroplasty
  NCT06426251 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: All (male and female)
• Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
  NCT06170788 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  NCT07222566 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration
  NCT05557487 · Phase: Not specified · Ages: 20 Years to 80 Years · Sex: All (male and female)
• The Impact of Multimedia Childbirth Prediction on Parturients and Their Spouses
  NCT06816186 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: All (male and female)
• ULTRA-high-risk Surveillance to Avoid Future Events: the ULTRA-SAFE Trial
  NCT07378930 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 75 Years · Sex: All (male and female)
• Virtual Forest-Based Mindfulness for Perinatal Mental Health
  NCT07606248 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female

Common questions

How many clinical trials are recruiting in Hsinchu, Taiwan?

36 recruiting trials have at least one study site in Hsinchu, Taiwan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.